WO2002064748A3 - Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof - Google Patents
Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof Download PDFInfo
- Publication number
- WO2002064748A3 WO2002064748A3 PCT/US2002/004652 US0204652W WO02064748A3 WO 2002064748 A3 WO2002064748 A3 WO 2002064748A3 US 0204652 W US0204652 W US 0204652W WO 02064748 A3 WO02064748 A3 WO 02064748A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- obtaining
- adult stem
- differentiation
- sources
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
- A01K67/027—New breeds of vertebrates
- A01K67/0271—Chimeric animals, e.g. comprising exogenous cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0619—Neurons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0622—Glial cells, e.g. astrocytes, oligodendrocytes; Schwann cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/106—Primate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/113—Acidic fibroblast growth factor (aFGF, FGF-1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/117—Keratinocyte growth factors (KGF-1, i.e. FGF-7; KGF-2, i.e. FGF-12)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/12—Hepatocyte growth factor [HGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/135—Platelet-derived growth factor [PDGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/235—Leukemia inhibitory factor [LIF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/237—Oncostatin M [OSM]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/08—Coculture with; Conditioned medium produced by cells of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/30—Coculture with; Conditioned medium produced by tumour cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/02—Cells from transgenic animals
Abstract
Priority Applications (20)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL15733202A IL157332A0 (en) | 2001-02-14 | 2002-02-14 | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
JP2002565063A JP2004529621A (en) | 2001-02-14 | 2002-02-14 | Pluripotent adult stem cells, their origin, methods of obtaining and maintaining them, methods of differentiating them, methods of their use, and cells derived therefrom |
EP02718998A EP1367899A4 (en) | 2001-02-14 | 2002-02-14 | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
CA2438501A CA2438501C (en) | 2001-02-14 | 2002-02-14 | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
NZ527527A NZ527527A (en) | 2001-02-14 | 2002-02-14 | Mammalian multipotent adult stem cells (MASC) with the capacity to differentiate into cells of mesodermal, ectodermal or endodermal origin and uses thereof |
US10/467,963 US7838289B2 (en) | 2001-02-14 | 2002-02-14 | Assay utilizing multipotent adult stem cells |
IL157332A IL157332A (en) | 2001-02-14 | 2003-08-11 | Method for providing cell population from umbilical cord blood or placenta which can differentiate into cell types of the embryonic lineage |
IL214623A IL214623A (en) | 2001-02-14 | 2003-08-11 | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof. methods of use thereof and cells derived therefrom |
ZA2003/06289A ZA200306289B (en) | 2001-02-14 | 2003-08-13 | Multipotent adult stem cells sources thereof methods of obtaining and maintaining same methods of differentiation thereof methods of use thereof and cells derived thereof |
US11/084,809 US20050283844A1 (en) | 2001-02-14 | 2005-03-21 | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
US11/587,511 US8609412B2 (en) | 1999-08-05 | 2005-04-21 | Mapc generation of lung tissue |
US11/151,689 US8075881B2 (en) | 1999-08-05 | 2005-06-13 | Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure |
US11/269,736 US8147824B2 (en) | 1999-08-05 | 2005-11-09 | Immunomodulatory properties of multipotent adult progenitor cells and uses thereof |
US11/446,560 US7927587B2 (en) | 1999-08-05 | 2006-06-02 | MAPC administration for the treatment of lysosomal storage disorders |
US12/093,159 US9962407B2 (en) | 1999-08-05 | 2006-11-09 | Immunomodulatory properties of multipotent adult progenitor cells and uses thereof |
US13/042,205 US20110177595A1 (en) | 2001-02-14 | 2011-03-07 | Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived Thereof |
US13/105,372 US8252280B1 (en) | 1999-08-05 | 2011-05-11 | MAPC generation of muscle |
IL214623A IL214623A0 (en) | 2001-02-14 | 2011-08-11 | Method for providing cell population from umbilical cord blood or placenta |
US13/301,186 US9526747B2 (en) | 1999-08-05 | 2011-11-21 | Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure |
US13/345,036 US9808485B2 (en) | 1999-08-05 | 2012-01-06 | Immunomodulatory properties of multipotent adult progenitor cells and uses thereof |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26878601P | 2001-02-14 | 2001-02-14 | |
US60/268,786 | 2001-02-14 | ||
US26906201P | 2001-02-15 | 2001-02-15 | |
US60/269,062 | 2001-02-15 | ||
US31062501P | 2001-08-07 | 2001-08-07 | |
US60/310,625 | 2001-08-07 | ||
US34338601P | 2001-10-25 | 2001-10-25 | |
US60/343,386 | 2001-10-25 |
Related Child Applications (9)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/021387 Continuation-In-Part WO2001011011A2 (en) | 1999-08-05 | 2000-08-04 | Multipotent adult stem cells and methods for isolation |
US10/467,963 A-371-Of-International US7838289B2 (en) | 1999-08-05 | 2002-02-14 | Assay utilizing multipotent adult stem cells |
US10467963 A-371-Of-International | 2002-02-14 | ||
US10/048,757 Continuation-In-Part US7015037B1 (en) | 1999-08-05 | 2002-08-21 | Multiponent adult stem cells and methods for isolation |
US96344404A Continuation-In-Part | 1999-08-05 | 2004-10-11 | |
US10/587,511 Continuation-In-Part US20070149331A1 (en) | 2004-01-30 | 2005-01-28 | Power transmission chain, manufacture method thereof and power transmission assembly |
US11/084,809 Continuation US20050283844A1 (en) | 2001-02-14 | 2005-03-21 | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
US11/446,560 Continuation-In-Part US7927587B2 (en) | 1999-08-05 | 2006-06-02 | MAPC administration for the treatment of lysosomal storage disorders |
US12/907,495 Continuation US10638734B2 (en) | 1999-08-05 | 2010-10-19 | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
Publications (4)
Publication Number | Publication Date |
---|---|
WO2002064748A2 WO2002064748A2 (en) | 2002-08-22 |
WO2002064748A8 WO2002064748A8 (en) | 2003-04-24 |
WO2002064748A3 true WO2002064748A3 (en) | 2003-08-21 |
WO2002064748A9 WO2002064748A9 (en) | 2006-03-30 |
Family
ID=27500956
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/004652 WO2002064748A2 (en) | 1999-08-05 | 2002-02-14 | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
Country Status (6)
Country | Link |
---|---|
US (3) | US7838289B2 (en) |
EP (2) | EP1367899A4 (en) |
JP (1) | JP2004529621A (en) |
CA (1) | CA2438501C (en) |
IL (4) | IL157332A0 (en) |
WO (1) | WO2002064748A2 (en) |
Families Citing this family (159)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040242520A1 (en) * | 1997-09-06 | 2004-12-02 | Mayo Foundation For Medical Education And Research, A Minnesota Corporation | Expression of immonogenic substances |
US8062675B2 (en) * | 1999-07-07 | 2011-11-22 | Angioblast Systems, Inc. | Mesenchymal precursor cell |
AUPQ147799A0 (en) * | 1999-07-07 | 1999-07-29 | Medvet Science Pty. Ltd. | Mesenchymal precursor cell |
AU2003901668A0 (en) * | 2003-03-28 | 2003-05-01 | Medvet Science Pty. Ltd. | Non-haemopoietic precursor cells |
US7670628B2 (en) * | 1999-07-07 | 2010-03-02 | Angioblast Systems, Inc. | Mesenchymal precursor cell |
US20050158289A1 (en) * | 1999-07-07 | 2005-07-21 | Simmons Paul J. | Mesenchymal precursor cell and use thereof in the repair of bone defects and fractures in mammals |
US8147824B2 (en) * | 1999-08-05 | 2012-04-03 | Athersys, Inc. | Immunomodulatory properties of multipotent adult progenitor cells and uses thereof |
US8609412B2 (en) | 1999-08-05 | 2013-12-17 | Regents Of The University Of Minnesota | Mapc generation of lung tissue |
US10638734B2 (en) | 2004-01-05 | 2020-05-05 | Abt Holding Company | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
US8252280B1 (en) | 1999-08-05 | 2012-08-28 | Regents Of The University Of Minnesota | MAPC generation of muscle |
US7838289B2 (en) | 2001-02-14 | 2010-11-23 | Abt Holding Company | Assay utilizing multipotent adult stem cells |
US7015037B1 (en) | 1999-08-05 | 2006-03-21 | Regents Of The University Of Minnesota | Multiponent adult stem cells and methods for isolation |
WO2005113748A2 (en) * | 2004-04-21 | 2005-12-01 | Regents Of The University Of Minnesota | Mapc generation of lung tissue |
US7291597B2 (en) * | 2000-04-06 | 2007-11-06 | Franco Wayne P | Growth factor therapy mobilization of stem cells into the peripheral blood |
AU2002220209B2 (en) | 2000-12-06 | 2006-05-25 | Robert J. Hariri | Method of collecting placental stem cells |
US7311905B2 (en) * | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
US20030032179A1 (en) * | 2000-12-06 | 2003-02-13 | Hariri Robert J. | Post-partum mammalian placenta, its use and placental stem cells therefrom |
KR101012952B1 (en) | 2001-02-14 | 2011-02-08 | 안트로제네시스 코포레이션 | Post-partum mammalian placenta, its use and placental stem cells therefrom |
DE10144326B4 (en) * | 2001-09-10 | 2005-09-22 | Siemens Ag | Method and system for monitoring a tire air pressure |
US9969980B2 (en) * | 2001-09-21 | 2018-05-15 | Garnet Biotherapeutics | Cell populations which co-express CD49c and CD90 |
JP2005514926A (en) | 2002-01-14 | 2005-05-26 | ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ | Novel mammalian multipotent stem cells and compositions, methods for their preparation and administration |
US20030228287A1 (en) * | 2002-06-07 | 2003-12-11 | Regents Of The University Of California | Maintenance of islet cells |
AU2003248609A1 (en) * | 2002-07-12 | 2004-02-02 | Agency For Science, Technology And Research | Hemangioblast progenitor cells |
US20040052771A1 (en) * | 2002-07-12 | 2004-03-18 | Lim Sai Kiang | Hemangioblast progenitor cells |
US7422736B2 (en) | 2002-07-26 | 2008-09-09 | Food Industry Research And Development Institute | Somatic pluripotent cells |
WO2004011012A2 (en) * | 2002-07-29 | 2004-02-05 | Asahi Kasei Kabushiki Kaisha | Stem cells for treating pancreatic damage |
AU2003278212B2 (en) * | 2002-07-31 | 2009-07-09 | Centre National De La Recherche Scientifique | Stem cells derived from adipous tissue and differentiated cells derived from said cells |
US9969977B2 (en) * | 2002-09-20 | 2018-05-15 | Garnet Biotherapeutics | Cell populations which co-express CD49c and CD90 |
US7074561B2 (en) * | 2002-10-22 | 2006-07-11 | Biomerieux, Inc. | Isothermal amplification based assay for the detection and quantitation of alpha-fetoprotein mRNA |
WO2004087896A2 (en) * | 2003-03-31 | 2004-10-14 | Pfizer Products Inc. | Hepatocyte differentiation of stem cells |
DE10362002B4 (en) | 2003-06-23 | 2006-10-12 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Adult pluripotent stem cells |
WO2005002601A1 (en) * | 2003-06-25 | 2005-01-13 | Badylak Stephen F | Conditioned matrix compositions for tissue restoration |
US9592258B2 (en) | 2003-06-27 | 2017-03-14 | DePuy Synthes Products, Inc. | Treatment of neurological injury by administration of human umbilical cord tissue-derived cells |
US8790637B2 (en) | 2003-06-27 | 2014-07-29 | DePuy Synthes Products, LLC | Repair and regeneration of ocular tissue using postpartum-derived cells |
US7875272B2 (en) | 2003-06-27 | 2011-01-25 | Ethicon, Incorporated | Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells |
US9572840B2 (en) | 2003-06-27 | 2017-02-21 | DePuy Synthes Products, Inc. | Regeneration and repair of neural tissue using postpartum-derived cells |
EP1641913B1 (en) | 2003-06-27 | 2016-01-06 | DePuy Synthes Products, Inc. | Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
WO2005003317A2 (en) * | 2003-07-01 | 2005-01-13 | Regents Of The University Of Minnesota | Engineered blood vessels |
WO2005035742A2 (en) | 2003-10-08 | 2005-04-21 | Vet-Stem Inc. | Methods of preparing and using stem cell compositions and kits comprising the same |
GB0329449D0 (en) * | 2003-12-19 | 2004-01-28 | Omnicyte Ltd | Stem cells |
WO2005095588A1 (en) * | 2004-03-31 | 2005-10-13 | Kyoto University | Cortex glutamatergic neuron precursor providing cortex glutamatergic neuron and cortex glutamatergic neuron precursor alone in vivo |
CA2563518C (en) * | 2004-04-23 | 2014-09-02 | Bioe, Inc. | Multi-lineage progenitor cells |
US7622108B2 (en) * | 2004-04-23 | 2009-11-24 | Bioe, Inc. | Multi-lineage progenitor cells |
EP1753439A2 (en) | 2004-05-17 | 2007-02-21 | Regents Of The University Of Minnesota | Use of umbilical cord blood stem cells to treat ischemic event |
US20080064034A1 (en) * | 2004-05-21 | 2008-03-13 | Fraunhofer-Gesellschaft Zur Förderung Der Angewand | Multi-Cellular Test Systems |
US20090104158A1 (en) * | 2004-09-03 | 2009-04-23 | Moraga Biotechnology Corporation | Non-Embryonic Totipotent Blastomere-Like Stem Cells And Methods Therefor |
KR101598947B1 (en) | 2004-09-24 | 2016-03-08 | 메소블라스트, 아이엔씨. | Method of enhancing proliferation and/or survival of mesenchymal precursor cells (mpc) |
GB2464652B (en) * | 2004-09-29 | 2010-06-30 | Cellartis Ab | Improved methods for the generation of hepatocyte-like cells from human blastocyst-derived stem (hBS) |
WO2006045331A1 (en) * | 2004-10-27 | 2006-05-04 | Vrije Universiteit Brussel | Differentiation of stem cells and stabilization of phenotypical properties of primary cells |
JP2008029201A (en) * | 2004-11-05 | 2008-02-14 | Hidechika Okada | Method for preparing stem cell and tissue remedy |
US7883535B2 (en) | 2004-11-09 | 2011-02-08 | Institut National D'optique | Device and method for transmitting multiple optically-encoded stimulation signals to multiple cell locations |
CA2592435C (en) | 2004-12-23 | 2017-03-28 | Ethicon, Incorporated | Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells |
WO2006086639A1 (en) | 2005-02-10 | 2006-08-17 | Regents Of The University Of Minnesota | Vascular/lymphatic endothelial cells |
CN101218341A (en) * | 2005-05-05 | 2008-07-09 | 明尼苏达大学董事会 | Use of NK cell inhibition to facilitate persistence of engrafted MHC-I negative cells |
WO2006121454A2 (en) * | 2005-05-05 | 2006-11-16 | Regents Of The University Of Minnesota | Use of mapc or progeny therefrom to populate lymphohematopoietic tissues |
JP2009509911A (en) * | 2005-05-05 | 2009-03-12 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | Use of MAPCs or their progeny to establish lymphatic hematopoietic tissue |
JP2008546385A (en) | 2005-06-16 | 2008-12-25 | ラモト アット テル アヴィヴ ユニヴァーシティ リミテッド | Isolated cells and populations containing isolated cells for treating CNS disease |
WO2007117262A2 (en) * | 2005-07-29 | 2007-10-18 | Athersys, Inc. | Culture of non-embryonic cells at high cell density |
EP1924606A4 (en) | 2005-08-25 | 2010-01-13 | Repair Technologies Inc | Devices, compositions and methods for the protection and repair of cells and tissues |
ES2452595T3 (en) | 2005-10-13 | 2014-04-02 | Anthrogenesis Corporation | Immunomodulation using placental stem cells |
US10117900B2 (en) | 2005-11-09 | 2018-11-06 | Athersys, Inc. | MAPC treatment of brain injuries and diseases |
US11000546B2 (en) * | 2005-11-09 | 2021-05-11 | Athersys, Inc. | Immunomodulatory properties of MAPCs and uses thereof |
KR100697326B1 (en) * | 2005-12-02 | 2007-03-20 | 재단법인서울대학교산학협력재단 | Multipotent Adult Stem Cells Having an Ability of Oct4 Expression Derived from Umbilical Cord Blood and Method for Preparing the Same |
PL1971681T3 (en) | 2005-12-16 | 2018-01-31 | Depuy Synthes Products Inc | Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation |
US9125906B2 (en) | 2005-12-28 | 2015-09-08 | DePuy Synthes Products, Inc. | Treatment of peripheral vascular disease using umbilical cord tissue-derived cells |
AU2006332679A1 (en) | 2005-12-29 | 2007-07-12 | Anthrogenesis Corporation | Co-culture of placental stem cells and stem cells from a second source |
KR20210122908A (en) | 2005-12-29 | 2021-10-12 | 안트로제네시스 코포레이션 | Placental stem cell populations |
CA3124132A1 (en) * | 2006-01-23 | 2007-08-02 | Abt Holding Company | Mapc therapeutics without adjunctive immunosuppressive treatment |
JP5432527B2 (en) | 2006-01-23 | 2014-03-05 | アサーシス,インコーポレーテッド | MAPC treatment of brain injury and disease |
EP2422800A3 (en) | 2006-03-07 | 2013-03-06 | Geeta Shroff | Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation |
US20070269411A1 (en) * | 2006-03-10 | 2007-11-22 | Wei Sun | Porous silicon materials and devices |
KR100871984B1 (en) | 2006-04-12 | 2008-12-05 | 주식회사 알앤엘바이오 | Multipotent Stem Cell Derived from Placenta Tissue and Cellular Therapeutic Agents Comprising the Same |
WO2007121443A2 (en) * | 2006-04-17 | 2007-10-25 | Bioe, Inc. | Differentiation of multi-lineage progenitor cells to respiratory epithelial cells |
US7989204B2 (en) | 2006-04-28 | 2011-08-02 | Viacyte, Inc. | Hepatocyte lineage cells |
KR100792184B1 (en) * | 2006-05-12 | 2008-01-07 | 재단법인서울대학교산학협력재단 | Mutipotent Adult Stem Cell Derived from Canine Umbilical Cord Blood, Placenta and Canine Fetus Heart, Method for Preparing the Same and Cellular Therapeutics Containing the Same |
US20080050814A1 (en) * | 2006-06-05 | 2008-02-28 | Cryo-Cell International, Inc. | Procurement, isolation and cryopreservation of fetal placental cells |
WO2007146105A2 (en) * | 2006-06-05 | 2007-12-21 | Cryo-Cell International, Inc. | Procurement, isolation and cryopreservation of fetal placental cells |
CN101501185A (en) * | 2006-06-09 | 2009-08-05 | 人类起源公司 | Placental niche and use thereof to culture stem cells |
US7875453B2 (en) * | 2006-06-14 | 2011-01-25 | Bioe Llc | Differentiation of multi-lineage progenitor cells to hepatocytes |
US7993918B2 (en) * | 2006-08-04 | 2011-08-09 | Anthrogenesis Corporation | Tumor suppression using placental stem cells |
KR100818213B1 (en) | 2006-09-22 | 2008-04-01 | 재단법인서울대학교산학협력재단 | Human Cord Blood Multipotent Stem Cell Having Enhanced Proliferation Ability With Osteoclast-based Niche-like Structure and Method for Preparing the Same |
KR100818214B1 (en) | 2006-09-29 | 2008-04-01 | 재단법인서울대학교산학협력재단 | Multipotent stem cell derived from amnion or decidua isolated from human term placenta and method for preparing the same |
DK2578081T3 (en) | 2006-10-11 | 2016-06-27 | Massachusetts Gen Hospital | Compositions, methods and devices for the treatment of liver disease |
DK2084268T3 (en) | 2006-10-23 | 2019-01-21 | Celularity Inc | METHODS AND COMPOSITIONS FOR TREATING BONE JOIN DEFECTS WITH PLACENTACLE POPULATIONS |
JP2010508854A (en) * | 2006-11-08 | 2010-03-25 | アルダジェン, インコーポレイテッド | Methods for improving engraftment after stem cell transplantation |
AU2007321928A1 (en) | 2006-11-24 | 2008-05-29 | Regents Of The University Of Minnesota | Endodermal progenitor cells |
DK2120977T3 (en) | 2007-02-12 | 2013-08-12 | Anthrogenesis Corp | Treatment of inflammatory diseases using placental stem cells |
WO2008101100A2 (en) * | 2007-02-14 | 2008-08-21 | Indiana University Research And Technology Corporation | Composition for stimulating formation of vascular structures |
EP2607477B1 (en) | 2007-05-03 | 2020-09-23 | The Brigham and Women's Hospital, Inc. | Multipotent stem cells and uses thereof |
US8574567B2 (en) * | 2007-05-03 | 2013-11-05 | The Brigham And Women's Hospital, Inc. | Multipotent stem cells and uses thereof |
TWM322542U (en) * | 2007-05-23 | 2007-11-21 | Universal Scient Ind Co Ltd | Testing machine |
JP2010529987A (en) * | 2007-06-15 | 2010-09-02 | ガーネット バイオセラピューティクス インコーポレイテッド | Treatment of diseases and disorders using self-replicating colony-forming cells cultured and grown in vitro |
US8273526B2 (en) | 2007-06-18 | 2012-09-25 | Children's Hospital & Research Center At Oakland | Method of isolating stem and progenitor cells from placenta |
CN101835479A (en) * | 2007-07-25 | 2010-09-15 | 佰欧益有限公司 | Differentiation of multi-lineage progenitor cells to chondrocytes |
KR20210022148A (en) | 2007-09-28 | 2021-03-02 | 안트로제네시스 코포레이션 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
WO2009061442A1 (en) * | 2007-11-06 | 2009-05-14 | Children's Medical Center Corporation | Method to produce induced pluripotent stem (ips) cells form non-embryonic human cells |
SG187493A1 (en) | 2008-01-18 | 2013-02-28 | Univ Minnesota | Stem cell aggregates and methods for making and using |
US20090233993A1 (en) * | 2008-03-06 | 2009-09-17 | Burnham Institute For Medical Research | Compositions and methods for inhibiting gsk3 activity and uses thereof |
GB2467982A (en) * | 2008-05-08 | 2010-08-25 | Coretherapix Slu | Pluripotent adult stem cells |
EP2294187A2 (en) * | 2008-05-21 | 2011-03-16 | BioE LLC | Differentiation of multi-lineage progenitor cells to pancreatic cells |
US8663987B2 (en) | 2008-05-28 | 2014-03-04 | Ramot At Tel-Aviv University Ltd. | Mesenchymal stem cells for the treatment of CNS diseases |
KR101903049B1 (en) | 2008-08-20 | 2018-11-07 | 안트로제네시스 코포레이션 | Treatment of stroke using isolated placental cells |
KR20110050521A (en) | 2008-08-20 | 2011-05-13 | 안트로제네시스 코포레이션 | Improved cell composition and methods of making the same |
KR20110050688A (en) | 2008-08-22 | 2011-05-16 | 안트로제네시스 코포레이션 | Methods and compositions for treatment of bone defects with placental cell populations |
GB0818725D0 (en) | 2008-10-13 | 2008-11-19 | Habib Nagy A | Pharmaceutical composition |
AU2009316541B2 (en) | 2008-11-19 | 2015-08-06 | Celularity Inc. | Amnion derived adherent cells |
US10179900B2 (en) | 2008-12-19 | 2019-01-15 | DePuy Synthes Products, Inc. | Conditioned media and methods of making a conditioned media |
US10557116B2 (en) | 2008-12-19 | 2020-02-11 | DePuy Synthes Products, Inc. | Treatment of lung and pulmonary diseases and disorders |
US8771677B2 (en) | 2008-12-29 | 2014-07-08 | Vladimir B Serikov | Colony-forming unit cell of human chorion and method to obtain and use thereof |
WO2010099539A1 (en) * | 2009-02-27 | 2010-09-02 | Cellular Dynamics International, Inc. | Differentiation of pluripotent cells |
KR100950195B1 (en) * | 2009-03-20 | 2010-03-29 | 서울대학교산학협력단 | Method for isolation of umbilical cord blood derived-pluripotent stem cell expressing znf281 |
AU2010229651B2 (en) | 2009-03-26 | 2014-05-08 | Advanced Technologies And Regenerative Medicine, Llc | Human umbilical cord tissue cells as therapy for Alzheimer' s disease |
EP2419511B1 (en) | 2009-04-09 | 2018-01-17 | Sangamo Therapeutics, Inc. | Targeted integration into stem cells |
JP2011010653A (en) * | 2009-06-05 | 2011-01-20 | Kumamoto Univ | Method for induction of cell differentiation |
WO2010144696A1 (en) | 2009-06-11 | 2010-12-16 | Burnham Institute For Medical Research | Directed differentiation of stem cells |
ES2679271T3 (en) * | 2009-07-09 | 2018-08-23 | Janssen Biotech, Inc. | Cells derived from cardiac tissue |
AU2010276201B2 (en) * | 2009-07-21 | 2013-10-17 | Abt Holding Company | Use of stem cells to reduce leukocyte extravasation |
EP2456860B1 (en) * | 2009-07-21 | 2018-09-05 | ABT Holding Company | Use of stem cells to reduce leukocyte extravasation |
WO2011082339A2 (en) * | 2009-12-31 | 2011-07-07 | Cedars-Sinai Medical Center | Regeneration of, reestablishing function in and replacing microvasculature in organs and tissues |
EP3284818B1 (en) | 2010-01-26 | 2022-03-09 | Celularity Inc. | Treatment of bone-related cancers using placental stem cells |
BR112012021451B8 (en) | 2010-02-25 | 2021-05-25 | Abt Holding Co | use of cells that have a desired efficiency for expression and/or secretion of the pro-angiogenic factors vegf, cxcl5 and il8, methods to build a cell bank, to develop drug, and to increase the expression of one or more pro-angiogenic factors angiogenic in a cell performed in vitro, and composition |
SG10201501402UA (en) | 2010-02-25 | 2015-04-29 | Abt Holding Co | Modulation of macrophage activation |
KR20230054905A (en) | 2010-04-07 | 2023-04-25 | 셀룰래리티 인코포레이티드 | Angiogenesis using placental stem cells |
WO2011127113A1 (en) | 2010-04-08 | 2011-10-13 | Anthrogenesis Corporation | Treatment of sarcoidosis using placental stem cells |
SG185526A1 (en) | 2010-05-12 | 2012-12-28 | Abt Holding Co | Modulation of splenocytes in cell therapy |
WO2011158125A2 (en) | 2010-06-17 | 2011-12-22 | Katholieke Universiteit Leuven | Methods for differentiating cells into hepatic stellate cells and hepatic sinusoidal endothelial cells, cells produced by the methods, and methods for using the cells |
RU2445106C1 (en) * | 2010-07-01 | 2012-03-20 | Закрытое Акционерное Общество "Фарм-Синтез" | Pharmaceutical composition for treating central and peripheral nervous system disorders of cardiovascular, traumatic, toxic, hypoxic and autoimmune genesis |
RU2428196C1 (en) * | 2010-07-01 | 2011-09-10 | Закрытое Акционерное Общество "Фарм-Синтез" | Method for preparing biologically active complex and biologically active protein-polypeptide complex |
ES2666746T3 (en) | 2010-07-13 | 2018-05-07 | Anthrogenesis Corporation | Methods to generate natural cytolytic lymphocytes |
AU2011293440B2 (en) | 2010-08-24 | 2016-05-05 | Katholieke Universiteit Leuven | Non-static suspension culture of cell aggregates |
US9725689B2 (en) | 2010-10-08 | 2017-08-08 | Terumo Bct, Inc. | Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system |
US8574899B2 (en) | 2010-12-22 | 2013-11-05 | Vladimir B Serikov | Methods for augmentation collection of placental hematopoietic stem cells and uses thereof |
US8969315B2 (en) | 2010-12-31 | 2015-03-03 | Anthrogenesis Corporation | Enhancement of placental stem cell potency using modulatory RNA molecules |
AU2012206411B2 (en) * | 2011-01-12 | 2017-05-18 | Tsuneo KIDO | Culture method to obtain and maintain a pure or enriched population of mammalian neural stem cells and/or neural progenitor cells that are prone to differentiate into oligodendrocyte-lineage cells |
AU2012236199A1 (en) * | 2011-03-30 | 2013-09-26 | Board Of Regents Of The University Of Texas System | Methods and compositions for targeting adipose cells in mammals |
PL2714059T3 (en) | 2011-06-01 | 2019-04-30 | Celularity Inc | Treatment of pain using placental stem cells |
PL2718416T3 (en) | 2011-06-06 | 2020-05-18 | ReGenesys BVBA | Expansion of stem cells in hollow fiber bioreactors |
WO2013055476A1 (en) | 2011-09-09 | 2013-04-18 | Anthrogenesis Corporation | Treatment of amyotrophic lateral sclerosis using placental stem cells |
SG11201403465PA (en) | 2011-12-23 | 2014-10-30 | Atrm Llc | Detection of human umbilical cord tissue-derived cells |
WO2013151725A1 (en) | 2012-04-05 | 2013-10-10 | The Regents Of The University Of California | Regenerative sera cells and mesenchymal stem cells |
US9763983B2 (en) | 2013-02-05 | 2017-09-19 | Anthrogenesis Corporation | Natural killer cells from placenta |
ES2827250T3 (en) | 2013-04-12 | 2021-05-20 | Houston Methodist Hospital | Improvement of organs for transplantation |
DK2992088T3 (en) | 2013-04-30 | 2019-11-11 | Univ Leuven Kath | CELL THERAPY FOR MYELODYSPLASTIC SYNDROMES |
WO2015073913A1 (en) | 2013-11-16 | 2015-05-21 | Terumo Bct, Inc. | Expanding cells in a bioreactor |
WO2015148704A1 (en) | 2014-03-25 | 2015-10-01 | Terumo Bct, Inc. | Passive replacement of media |
CN106715676A (en) | 2014-09-26 | 2017-05-24 | 泰尔茂比司特公司 | Scheduled feed |
EP3307874A4 (en) | 2015-06-12 | 2019-04-24 | Agency For Science, Technology And Research | Derivation of hepatic stem cells and mature liver cell types and uses thereof |
WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
WO2017062401A1 (en) | 2015-10-05 | 2017-04-13 | ORIG3N Inc. | Diagnosis and treatment of parkinson's disease based on identification and amelioration of liver dysfunction |
SG11201806245TA (en) | 2016-01-21 | 2018-08-30 | Abt Holding Co | Stem cells for wound healing |
US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
CN114176043A (en) * | 2016-06-14 | 2022-03-15 | 明尼苏达大学董事会 | Genetically modified cells, tissues and organs for the treatment of diseases |
US11702634B2 (en) | 2017-03-31 | 2023-07-18 | Terumo Bct, Inc. | Expanding cells in a bioreactor |
US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
AU2019377532A1 (en) * | 2018-11-09 | 2021-06-10 | Figene, Llc | Regenerative abscopal effects |
US20200246390A1 (en) | 2019-02-01 | 2020-08-06 | Abt Holding Company | Multipotent adult projenitor cells for treatment of ich |
US11697799B2 (en) * | 2019-04-15 | 2023-07-11 | Ossium Health, Inc. | System and method for extraction and cryopreservation of bone marrow |
JP2023516484A (en) | 2020-03-11 | 2023-04-19 | ビット バイオ リミテッド | Hepatocyte production method |
Family Cites Families (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4965204A (en) * | 1984-02-06 | 1990-10-23 | The Johns Hopkins University | Human stem cells and monoclonal antibodies |
US4714680B1 (en) * | 1984-02-06 | 1995-06-27 | Univ Johns Hopkins | Human stem cells |
US5130144B1 (en) * | 1984-02-06 | 1995-08-15 | Univ Johns Hopkins | Human stem cells and monoclonal antibodies |
US5087570A (en) * | 1988-05-10 | 1992-02-11 | Weissman Irving L | Homogeneous mammalian hematopoietic stem cell composition |
US5635386A (en) * | 1989-06-15 | 1997-06-03 | The Regents Of The University Of Michigan | Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture |
US5061620A (en) * | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
US5733542A (en) * | 1990-11-16 | 1998-03-31 | Haynesworth; Stephen E. | Enhancing bone marrow engraftment using MSCS |
US5486359A (en) * | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
US5197985A (en) * | 1990-11-16 | 1993-03-30 | Caplan Arnold I | Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells |
WO1994000484A1 (en) * | 1992-06-22 | 1994-01-06 | Young Henry E | Scar inhibitory factor and use thereof |
US5672499A (en) * | 1992-07-27 | 1997-09-30 | California Institute Of Technology | Immoralized neural crest stem cells and methods of making |
US5589376A (en) * | 1992-07-27 | 1996-12-31 | California Institute Of Technology | Mammalian neural crest stem cells |
US5654183A (en) * | 1992-07-27 | 1997-08-05 | California Institute Of Technology | Genetically engineered mammalian neural crest stem cells |
GB9308271D0 (en) * | 1993-04-21 | 1993-06-02 | Univ Edinburgh | Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method |
NZ314644A (en) | 1993-05-24 | 2000-11-24 | Immunex Corp | Use of flt3-ligands as a growth stimulator of stem cells in the transplantation of tissue |
WO1995003062A1 (en) * | 1993-07-21 | 1995-02-02 | Cellpro, Incorporated | Methods and compositions for preventing immune rejection of solid organ grafts |
WO1995010599A1 (en) | 1993-10-15 | 1995-04-20 | The University Of Melbourne | Embryonic stem cell-like cells |
US6015671A (en) * | 1995-06-07 | 2000-01-18 | Indiana University Foundation | Myocardial grafts and cellular compositions |
US5602301A (en) * | 1993-11-16 | 1997-02-11 | Indiana University Foundation | Non-human mammal having a graft and methods of delivering protein to myocardial tissue |
US5486659A (en) * | 1994-03-08 | 1996-01-23 | Rosenbush; Stuart W. | Stethoscope protection device and method for using same |
DE4441327C1 (en) * | 1994-11-22 | 1995-11-09 | Inst Pflanzengenetik & Kultur | Embryonic heart muscle cells, their production and their use |
US5648248A (en) * | 1994-12-30 | 1997-07-15 | Boehringer Ingelheim International Gmbh | Methods for producing differentiated cells from immature hematopoietic cells |
US5843780A (en) * | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
US5736396A (en) * | 1995-01-24 | 1998-04-07 | Case Western Reserve University | Lineage-directed induction of human mesenchymal stem cell differentiation |
GB9502022D0 (en) * | 1995-02-02 | 1995-03-22 | Abuljadayel Ilham M S | A method for preparing lymphohaematopoietic progenitor cells |
US5906934A (en) * | 1995-03-14 | 1999-05-25 | Morphogen Pharmaceuticals, Inc. | Mesenchymal stem cells for cartilage repair |
US6653134B2 (en) * | 1995-03-28 | 2003-11-25 | Cp Hahnemann University | Isolated stromal cells for use in the treatment of diseases of the central nervous system |
US6306575B1 (en) * | 1995-06-16 | 2001-10-23 | Stemcell Technologies, Inc. | Methods for preparing enriched human hematopoietic cell preparations |
CA2191655C (en) | 1995-12-01 | 2010-01-12 | Terry E. Thomas | Novel antibody compositions for preparing enriched human hematopoietic and tumor cell preparations |
US20010012513A1 (en) * | 1996-08-19 | 2001-08-09 | University Of Massachusetts | Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
US6787355B1 (en) | 1996-08-26 | 2004-09-07 | Mcgill University | Multipotent neural stem cells from peripheral tissues and uses thereof |
CA2267220A1 (en) * | 1996-10-11 | 1998-04-23 | The Texas A & M University System | Methods for the generation of primordial germ cells and transgenic animal species |
US6090622A (en) * | 1997-03-31 | 2000-07-18 | The Johns Hopkins School Of Medicine | Human embryonic pluripotent germ cells |
US5968829A (en) | 1997-09-05 | 1999-10-19 | Cytotherapeutics, Inc. | Human CNS neural stem cells |
WO1999015629A1 (en) | 1997-09-25 | 1999-04-01 | Cytomatrix, Llc | Methods and devices for the long-term culture of hematopoietic progenitor cells |
US6093531A (en) | 1997-09-29 | 2000-07-25 | Neurospheres Holdings Ltd. | Generation of hematopoietic cells from multipotent neural stem cells |
WO1999027076A1 (en) | 1997-11-25 | 1999-06-03 | Arc Genomic Research | Pluripotent embryonic stem cells and methods of obtaining them |
IL137101A0 (en) | 1998-01-12 | 2001-06-14 | Cold Spring Harbor Lab | Extension of cellular lifespan, methods and reagents |
WO1999053021A1 (en) | 1998-04-09 | 1999-10-21 | Bresagen Limited | Cell differentiation/proliferation and maintenance factor and uses thereof |
CA2328425A1 (en) * | 1998-05-22 | 1999-12-02 | Osiris Therapeutics, Inc. | Production of megakaryocytes by co-culturing human mesenchymal stem cells with cd34+ cells |
DE19833476B4 (en) * | 1998-07-24 | 2005-08-25 | Huss, Ralf, Dr. | Genetically modified CD34 negatives, adherently growing hematopoietic stem cells and their use in gene therapy |
AU3881499A (en) | 1998-09-01 | 2000-03-21 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells with compatible histocompatibility genes |
EP1146837A4 (en) | 1998-11-30 | 2002-10-31 | Ivf Sciences Colorado Inc | System and sequential culture media for in vitro fertilization |
US6777231B1 (en) * | 1999-03-10 | 2004-08-17 | The Regents Of The University Of California | Adipose-derived stem cells and lattices |
US20050169896A1 (en) * | 1999-05-14 | 2005-08-04 | Henry Ford Health System | Bone marrow transplantation for treatment of stroke |
AUPQ147799A0 (en) | 1999-07-07 | 1999-07-29 | Medvet Science Pty. Ltd. | Mesenchymal precursor cell |
DE60040292D1 (en) | 1999-07-20 | 2008-10-30 | Univ Southern California | IDENTIFICATION OF PLURIPOTENTAL PREMESESCHYMAL, PREMHEMOTOPOIETIC TEMPORARY CELLS |
WO2001008691A1 (en) | 1999-07-29 | 2001-02-08 | Steven Baranowitz | Methods for transdifferentiation of body tissues |
US7015037B1 (en) * | 1999-08-05 | 2006-03-21 | Regents Of The University Of Minnesota | Multiponent adult stem cells and methods for isolation |
US8609412B2 (en) * | 1999-08-05 | 2013-12-17 | Regents Of The University Of Minnesota | Mapc generation of lung tissue |
US8147824B2 (en) * | 1999-08-05 | 2012-04-03 | Athersys, Inc. | Immunomodulatory properties of multipotent adult progenitor cells and uses thereof |
US7927587B2 (en) * | 1999-08-05 | 2011-04-19 | Regents Of The University Of Minnesota | MAPC administration for the treatment of lysosomal storage disorders |
IL147990A0 (en) * | 1999-08-05 | 2002-09-12 | Mcl Llc | Multipotent adult stem cells and methods for isolation |
US8075881B2 (en) * | 1999-08-05 | 2011-12-13 | Regents Of The University Of Minnesota | Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure |
US7838289B2 (en) | 2001-02-14 | 2010-11-23 | Abt Holding Company | Assay utilizing multipotent adult stem cells |
EP1218487A2 (en) | 1999-09-23 | 2002-07-03 | Cell Science Therapeutics | Methods and devices for obtaining non-hematopoietic lineage cells from hematopoietic progenitor cells |
WO2001021767A2 (en) | 1999-09-24 | 2001-03-29 | Morphogen Pharmaceuticals, Inc. | Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
WO2001023528A1 (en) | 1999-09-27 | 2001-04-05 | University Of Florida Research Foundation | Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures |
AU782385B2 (en) | 1999-10-15 | 2005-07-21 | Advanced Cell Technology, Inc. | Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
US6280718B1 (en) * | 1999-11-08 | 2001-08-28 | Wisconsin Alumni Reasearch Foundation | Hematopoietic differentiation of human pluripotent embryonic stem cells |
CN100475953C (en) * | 1999-12-06 | 2009-04-08 | 通用医疗公司 | Pancreatic stem cells |
WO2001051610A1 (en) | 2000-01-14 | 2001-07-19 | Bresagen Limited | Ectoderm cell production |
US6602711B1 (en) | 2000-02-21 | 2003-08-05 | Wisconsin Alumni Research Foundation | Method of making embryoid bodies from primate embryonic stem cells |
ATE384124T1 (en) * | 2000-02-26 | 2008-02-15 | Artecel Inc | PLURIPOTENT STEM CELLS CREATED FROM ADIATIVE TISSUE STROMAL CELLS AND THEIR USES |
US7005252B1 (en) | 2000-03-09 | 2006-02-28 | Wisconsin Alumni Research Foundation | Serum free cultivation of primate embryonic stem cells |
JP4889902B2 (en) | 2000-03-14 | 2012-03-07 | イーエス・セル・インターナショナル・プライヴェート・リミテッド | Method for producing human neural progenitor cells from human embryonic stem (hES) cells, method for producing neurons using the method, method for producing oligodendrocytes or astrocytes |
EP1176189A1 (en) | 2000-07-21 | 2002-01-30 | Fornix Biosciences N.V. | Stem cell-like cells |
AU2001284695A1 (en) * | 2000-07-31 | 2002-02-13 | New York Medical College | Methods and compositions for the repair and/or regeneration of damaged myocardium |
GB0026252D0 (en) | 2000-10-26 | 2000-12-13 | Univ Edinburgh | Pluripotential stem cells |
US7560280B2 (en) * | 2000-11-03 | 2009-07-14 | Kourion Therapeutics Gmbh | Human cord blood derived unrestricted somatic stem cells (USSC) |
US7311905B2 (en) * | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
US20030032179A1 (en) * | 2000-12-06 | 2003-02-13 | Hariri Robert J. | Post-partum mammalian placenta, its use and placental stem cells therefrom |
AU2002220209B2 (en) * | 2000-12-06 | 2006-05-25 | Robert J. Hariri | Method of collecting placental stem cells |
US7056738B2 (en) * | 2001-03-23 | 2006-06-06 | Tulane University | Early stage multipotential stem cells in colonies of bone marrow stromal cells |
KR100449141B1 (en) * | 2001-04-19 | 2004-09-21 | (주)라이프코드 | Method for differentiating a mesenchymal stem cell into neural cells |
US20030003090A1 (en) * | 2001-05-31 | 2003-01-02 | Prockop Darwin J. | Directed in vitro differentiation of marrow stromal cells into neural cell progenitors |
US9969980B2 (en) * | 2001-09-21 | 2018-05-15 | Garnet Biotherapeutics | Cell populations which co-express CD49c and CD90 |
WO2004050859A2 (en) * | 2002-11-27 | 2004-06-17 | Regents Of The University Of Minnesota | Homologous recombination in multipotent adult progenitor cells |
US20040235165A1 (en) * | 2003-05-19 | 2004-11-25 | Darwin Prockop | In vitro differentiation of adult stem cells |
WO2005003317A2 (en) * | 2003-07-01 | 2005-01-13 | Regents Of The University Of Minnesota | Engineered blood vessels |
US8426200B2 (en) * | 2003-07-02 | 2013-04-23 | Regents Of The University Of Minnesota | Neuronal differentiation of stem cells |
AU2004269409A1 (en) * | 2003-08-29 | 2005-03-10 | Regents Of The University Of Minnesota | Kidney derived stem cells and methods for their isolation, differentiation and use |
-
2002
- 2002-02-14 US US10/467,963 patent/US7838289B2/en active Active
- 2002-02-14 EP EP02718998A patent/EP1367899A4/en not_active Withdrawn
- 2002-02-14 JP JP2002565063A patent/JP2004529621A/en not_active Withdrawn
- 2002-02-14 WO PCT/US2002/004652 patent/WO2002064748A2/en active Application Filing
- 2002-02-14 CA CA2438501A patent/CA2438501C/en not_active Expired - Lifetime
- 2002-02-14 EP EP04023157.3A patent/EP1491093B1/en not_active Expired - Lifetime
- 2002-02-14 IL IL15733202A patent/IL157332A0/en unknown
-
2003
- 2003-08-11 IL IL157332A patent/IL157332A/en active IP Right Grant
- 2003-08-11 IL IL214623A patent/IL214623A/en active IP Right Grant
-
2005
- 2005-03-21 US US11/084,809 patent/US20050283844A1/en not_active Abandoned
-
2011
- 2011-03-07 US US13/042,205 patent/US20110177595A1/en not_active Abandoned
- 2011-08-11 IL IL214623A patent/IL214623A0/en unknown
Non-Patent Citations (10)
Title |
---|
CARGILL M. ET AL.: "Characterization of single-nucleotide polymorphisms in coding regions of human genes", NATURE GENETICS, vol. 22, July 1999 (1999-07-01), pages 231 - 238, XP002121300 * |
GEIGER H. ET AL.: "Globin gene expression is reprogrammed in chimeras generated by injecting adult hematopoietic stem cells into mouse blastocysts", CELL, vol. 93, no. 6, 12 June 1998 (1998-06-12), pages 1055 - 1065, XP000941662 * |
GEISSLER E.K. ET AL.: "Effective use of donor MHC class I gene therapy in organ transplantation prevention of antibody-mediated hyperacute heart allograft rejection in highly sensitized rat recipients", HUMAN GENE THERAPY, vol. 11, no. 3, 2000, pages 459 - 469, XP002954855 * |
GRIGORIADOU K. ET AL.: "MHC class in molecules alone control NK-mediated bone marrow graft rejection", EUROPEAN JOURNAL OF IMMUNOLOGY, vol. 29, no. 11, November 1999 (1999-11-01), pages 3683 - 3690, XP002954854 * |
GULCHER J. ET AL.: "Population genetics: laying the groundwork for genetic disease modeling and targeting", CLINICAL CHEMICAL LABORATORY MEDICINE, vol. 36, no. 8, 1998, pages 523 - 527, XP002941805 * |
HUILIN Q. ET AL.: "Identification of genes responsible for bone differentiation from human bone marrow derived multipotent adult stem cells (MASC)", BLOOD, vol. 96, no. 11, PART 1, 16 November 2000 (2000-11-16), pages 70A - 71A, ABS. 298, XP002955582 * |
KEENE C.D. ET AL.: "Phenotypic expression of transplanted human bone marrow-derived multipotent adult stem cells into the rat CNS", EXPERIMENTAL NEUROLOGY, vol. 164, no. 2, August 2000 (2000-08-01), pages 465, XP002954852 * |
KUZNETSOV S.A. ET AL.: "Factors required for bone marrow stromal fibroblast colony formation in vitro", BRITISH JOURNAL OF HEMATOLOGY, vol. 97, no. 3, June 1997 (1997-06-01), pages 561 - 570, XP002954851 * |
MARMUR R. ET AL.: "Isolation and developmental characterization of cerebral cortical multipotent progenitors", DEVELOPMENTAL BIOLOGY, vol. 204, no. 2, 1998, pages 577 - 591, XP002954853 * |
REYES M. ET AL.: "Characterization of multipotent adult progenitor cells, a subpopulation of mesenchymal stem cells", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, vol. 938, 2001, pages 231 - 235, XP002954850 * |
Also Published As
Publication number | Publication date |
---|---|
EP1367899A4 (en) | 2004-07-28 |
CA2438501A1 (en) | 2002-08-22 |
US20050283844A1 (en) | 2005-12-22 |
US7838289B2 (en) | 2010-11-23 |
US20040107453A1 (en) | 2004-06-03 |
IL214623A (en) | 2012-10-31 |
WO2002064748A2 (en) | 2002-08-22 |
EP1491093B1 (en) | 2013-07-31 |
EP1367899A2 (en) | 2003-12-10 |
CA2438501C (en) | 2014-09-16 |
EP1491093A3 (en) | 2005-05-04 |
IL157332A0 (en) | 2004-02-19 |
WO2002064748A8 (en) | 2003-04-24 |
IL214623A0 (en) | 2011-09-27 |
US20110177595A1 (en) | 2011-07-21 |
EP1491093A2 (en) | 2004-12-29 |
IL157332A (en) | 2011-11-30 |
JP2004529621A (en) | 2004-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002064748A8 (en) | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof | |
WO2001011011A3 (en) | Multipotent adult stem cells and methods for isolation | |
WO2006134602A3 (en) | Isolated cells and populations comprising same for the treatment of cns diseases | |
WO2003059276A3 (en) | Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof | |
WO2003014317A3 (en) | Compositions and methods for isolation, propagation, and differentiation of human stem cells and uses thereof | |
WO2006044204A3 (en) | Neuronal progenitors from feeder-free human embryonic stem cell culture | |
WO2003099771A3 (en) | Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases | |
WO2006092668A3 (en) | Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same | |
MXPA05004225A (en) | Neutralizing antibodies against gdf-8 and uses therefor. | |
BR0214029A (en) | Methods and compositions for using stromal cells to support embryonic and adult stem cells | |
AU2003296958A1 (en) | Therapeutic retroviral vectors for gene therapy | |
WO2003066661A3 (en) | Human dr4 antibodies and uses thereof | |
WO2004047747A3 (en) | Compositions and methods for cell dedifferentiation and tissue regeneration | |
WO2007024441A3 (en) | Compositions of cells enriched for combinations of various stem and progenitor cell populations, methods of use thereof and methods of private banking thereof | |
AU7634801A (en) | Three-dimensional skin model | |
ZA200404101B (en) | In vitro culture of Mesenchymal Stem Cells (MSC) and a process for the preparation thereof for therapeutic use. | |
WO2002064088A3 (en) | Pharmaceutical composition for the treatment of alopecia | |
WO2001079164A3 (en) | N-substituted dithiocarbamates for the treatment of biological disorders | |
WO2003046161A3 (en) | Method for carrying out the ex vivo expansion and ex vivo differentiation of multipotent stem cells | |
WO2001068828A3 (en) | Compositions and methods for regulated protein expression in gut | |
WO2004043990A3 (en) | Human stem cell materials and methods | |
HK1068227A1 (en) | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof | |
WO2003039591A3 (en) | Allogenic vaccine that contains a costimulatory polypeptide-expressing tumor cell | |
WO2005052140A3 (en) | Multipotent postnatal stem cells from human periodontal ligament and uses thereof | |
WO2004043373A3 (en) | Precursor n-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
CFP | Corrected version of a pamphlet front page |
Free format text: REVISED ABSTRACT RECEIVED BY THE INTERNATIONAL BUREAU AFTER COMPLETION OF THE TECHNICAL PREPARATIONS FOR INTERNATIONAL PUBLICATION |
|
WWE | Wipo information: entry into national phase |
Ref document number: 157332 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 527527 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003/06289 Country of ref document: ZA Ref document number: 2438501 Country of ref document: CA Ref document number: 200306289 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002565063 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002250106 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002718998 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002718998 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10467963 Country of ref document: US |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002718998 Country of ref document: EP |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWP | Wipo information: published in national office |
Ref document number: 527527 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 527527 Country of ref document: NZ |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1-95, DESCRIPTION, REPLACED BY NEW PAGES 1-225; PAGES 96-105, CLAIMS, REPLACED BY NEW PAGES 226-235 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 214623 Country of ref document: IL |